Gonadotropin releasing hormone antagonist

  • US 6,653,286 B1
  • Filed: 12/20/1999
  • Issued: 11/25/2003
  • Est. Priority Date: 06/20/1997
  • Status: Expired due to Term
First Claim
Patent Images

1. A method for attenuating LH rise in women undergoing controlled ovarian hyperstimulation by administering exogenous FSH, said method comprising administering cojointly FSH and parenterally administering ganirelix in a daily dose of between 0.125 mg and 0.5 mg.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×